Effect of Screening and Adjuvant Therapy on Mortality from Breast Cancer
Donald A. Berry, Ph.D., Kathleen A. Cronin, Ph.D., Sylvia K. Plevritis, Ph.D., Dennis G. Fryback, Ph.D., Lauren Clarke, M.S., Marvin Zelen, Ph.D., Jeanne S. Mandelblatt, Ph.D., Andrei Y. Yakovlev, Ph.D., J. Dik F. Habbema, Ph.D., Eric J. Feuer, Ph.D., for the Cancer Intervention and Surveillance Modeling Network (CISNET) Collaborators
Background We used modeling techniques to assess the relativeand absolute contributions of screening mammography and adjuvanttreatment to the reduction in breast-cancer mortality in theUnited States from 1975 to 2000.
Methods A consortium of investigators developed seven independentstatistical models of breast-cancer incidence and mortality.All seven groups used the same sources to obtain data on theuse of screening mammography, adjuvant treatment, and benefitsof treatment with respect to the rate of death from breast cancer.
Results The proportion of the total reduction in the rate ofdeath from breast cancer attributed to screening varied in theseven models from 28 to 65 percent (median, 46 percent), withadjuvant treatment contributing the rest. The variability acrossmodels in the absolute contribution of screening was largerthan it was for treatment, reflecting the greater uncertaintyassociated with estimating the benefit of screening.
Conclusions Seven statistical models showed that both screeningmammography and treatment have helped reduce the rate of deathfrom breast cancer in the United States.
Source Information
From M.D. Anderson Cancer Center, Houston (D.A.B.); the National Cancer Institute, Bethesda, Md. (K.A.C., E.J.F.); Stanford University, Stanford, Calif. (S.K.P.); the University of Wisconsin–Madison, Madison (D.G.F.); Cornerstone Systems, Lynden, Wash. (L.C.); Dana–Farber Cancer Institute, Boston (M.Z.); Georgetown University, Washington, D.C. (J.S.M.); the University of Rochester, Rochester, N.Y. (A.Y.Y.); and Erasmus University Medical Center, Rotterdam, the Netherlands (J.D.F.H.).
Address reprint requests to Dr. Berry at the Department of Biostatistics and Applied Mathematics, M.D. Anderson Cancer Center, Unit 447, 1515 Holcombe Blvd., Houston, TX 77030, or at dberry{at}mdanderson.org.
Screening and Breast Cancer
Baker S. G., Gøtzsche P. C., Baglioni P., Smith D. W., Retsky M. W., Demicheli R., Hrushesky W. J.M., Berry D. A., Plevritis S. K., Fryback D. G.
Extract |
Full Text |
PDF
N Engl J Med 2006;
354:767-769, Feb 16, 2006.
Correspondence
This article has been cited by other articles:
Kurian, A. W., Sigal, B. M., Plevritis, S. K.
(2010). Survival Analysis of Cancer Risk Reduction Strategies for BRCA1/2 Mutation Carriers. JCO
28: 222-231
[Abstract][Full Text]
Anderson, W. F., Jatoi, I., Tse, J., Rosenberg, P. S.
(2010). Male Breast Cancer: A Population-Based Comparison With Female Breast Cancer. JCO
28: 232-239
[Abstract][Full Text]
Jorgensen, K. J., Gotzsche, P. C
(2010). Who evaluates public health programmes? A review of the NHS Breast Screening Programme. JRSM
103: 14-20
[Full Text]
Abbey, C. K., Eckstein, M. P., Boone, J. M.
(2010). An Equivalent Relative Utility Metric for Evaluating Screening Mammography. Med Decis Making
30: 113-122
[Abstract]
Kopans, D. B.
(2009). Mammography: Yet Another Challenge. Radiology
253: 587-589
[Full Text]
Cook, N. R., Rosner, B. A., Hankinson, S. E., Colditz, G. A.
(2009). Mammographic Screening and Risk Factors for Breast Cancer. Am J Epidemiol
170: 1422-1432
[Abstract][Full Text]
Tinsley, H. N., Gary, B. D., Keeton, A. B., Zhang, W., Abadi, A. H., Reynolds, R. C., Piazza, G. A.
(2009). Sulindac sulfide selectively inhibits growth and induces apoptosis of human breast tumor cells by phosphodiesterase 5 inhibition, elevation of cyclic GMP, and activation of protein kinase G. Molecular Cancer Therapeutics
8: 3331-3340
[Abstract][Full Text]
U.S. Preventive Services Task Force,
(2009). Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement. ANN INTERN MED
151: 716-726
[Abstract][Full Text]
Nelson, H. D., Tyne, K., Naik, A., Bougatsos, C., Chan, B. K., Humphrey, L.
(2009). Screening for Breast Cancer: An Update for the U.S. Preventive Services Task Force. ANN INTERN MED
151: 727-737
[Abstract][Full Text]
Mandelblatt, J. S., Cronin, K. A., Bailey, S., Berry, D. A., de Koning, H. J., Draisma, G., Huang, H., Lee, S. J., Munsell, M., Plevritis, S. K., Ravdin, P., Schechter, C. B., Sigal, B., Stoto, M. A., Stout, N. K., van Ravesteyn, N. T., Venier, J., Zelen, M., Feuer, E. J., for the Breast Cancer Working Group of the Cancer,
(2009). Effects of Mammography Screening Under Different Screening Schedules: Model Estimates of Potential Benefits and Harms. ANN INTERN MED
151: 738-747
[Abstract][Full Text]
Bosco, J. L.F., Lash, T. L., Prout, M. N., Buist, D. S.M., Geiger, A. M., Haque, R., Wei, F., Silliman, R. A., for the BOW Investigators,
(2009). Breast Cancer Recurrence in Older Women Five to Ten Years after Diagnosis. Cancer Epidemiol. Biomarkers Prev.
18: 2979-2983
[Abstract][Full Text]
Howard, D. H., Richardson, L. C., Thorpe, K. E.
(2009). Cancer Screening And Age In The United States And Europe. Health Aff (Millwood)
28: 1838-1847
[Abstract][Full Text]
Esserman, L., Shieh, Y., Thompson, I.
(2009). Rethinking Screening for Breast Cancer and Prostate Cancer. JAMA
302: 1685-1692
[Abstract][Full Text]
Hambly, N. M., McNicholas, M. M., Phelan, N., Hargaden, G. C., O'Doherty, A., Flanagan, F. L.
(2009). Comparison of Digital Mammography and Screen-Film Mammography in Breast Cancer Screening: A Review in the Irish Breast Screening Program. Am. J. Roentgenol.
193: 1010-1018
[Abstract][Full Text]
Stephenson, A. J., Kattan, M. W., Eastham, J. A., Bianco, F. J. Jr, Yossepowitch, O., Vickers, A. J., Klein, E. A., Wood, D. P., Scardino, P. T.
(2009). Prostate Cancer-Specific Mortality After Radical Prostatectomy for Patients Treated in the Prostate-Specific Antigen Era. JCO
27: 4300-4305
[Abstract][Full Text]
Menashe, I., Anderson, W. F., Jatoi, I., Rosenberg, P. S.
(2009). Underlying Causes of the Black-White Racial Disparity in Breast Cancer Mortality: A Population-Based Analysis. JNCI J Natl Cancer Inst
101: 993-1000
[Abstract][Full Text]
Nimmagadda, S., Pullambhatla, M., Pomper, M. G.
(2009). Immunoimaging of CXCR4 Expression in Brain Tumor Xenografts Using SPECT/CT. JNM
50: 1124-1130
[Abstract][Full Text]
Guarneri, V., Conte, P.
(2009). Metastatic Breast Cancer: Therapeutic Options According to Molecular Subtypes and Prior Adjuvant Therapy. The Oncologist
14: 645-656
[Abstract][Full Text]
Cheang, M. C. U., Chia, S. K., Voduc, D., Gao, D., Leung, S., Snider, J., Watson, M., Davies, S., Bernard, P. S., Parker, J. S., Perou, C. M., Ellis, M. J., Nielsen, T. O.
(2009). Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer. JNCI J Natl Cancer Inst
101: 736-750
[Abstract][Full Text]
Muss, H. B., Berry, D. A., Cirrincione, C. T., Theodoulou, M., Mauer, A. M., Kornblith, A. B., Partridge, A. H., Dressler, L. G., Cohen, H. J., Becker, H. P., Kartcheske, P. A., Wheeler, J. D., Perez, E. A., Wolff, A. C., Gralow, J. R., Burstein, H. J., Mahmood, A. A., Magrinat, G., Parker, B. A., Hart, R. D., Grenier, D., Norton, L., Hudis, C. A., Winer, E. P., the CALGB Investigators,
(2009). Adjuvant Chemotherapy in Older Women with Early-Stage Breast Cancer. NEJM
360: 2055-2065
[Abstract][Full Text]
Liu, X., Abdelrahim, M., Abudayyeh, A., Lei, P., Safe, S.
(2009). The nonsteroidal anti-inflammatory drug tolfenamic acid inhibits BT474 and SKBR3 breast cancer cell and tumor growth by repressing erbB2 expression. Molecular Cancer Therapeutics
8: 1207-1217
[Abstract][Full Text]
Falandry, C., Canney, P. A., Freyer, G., Dirix, L. Y.
(2009). Role of combination therapy with aromatase and cyclooxygenase-2 inhibitors in patients with metastatic breast cancer. Ann Oncol
20: 615-620
[Abstract][Full Text]
McArthur, H. L., Gelmon, K. A., Olivotto, I. A., Speers, C. H., Ellard, S. L., O'Reilly, S. E., Kennecke, H. F.
(2009). Effectiveness of a Letter Notification Program for Women With Early-Stage Breast Cancer Eligible for Extended Adjuvant Letrozole. JCO
27: 1388-1393
[Abstract][Full Text]
Snyder, C. F., Frick, K. D., Kantsiper, M. E., Peairs, K. S., Herbert, R. J., Blackford, A. L., Wolff, A. C., Earle, C. C.
(2009). Prevention, Screening, and Surveillance Care for Breast Cancer Survivors Compared With Controls: Changes from 1998 to 2002. JCO
27: 1054-1061
[Abstract][Full Text]
Ahern, C. H., Shen, Y.
(2009). Cost-Effectiveness Analysis of Mammography and Clinical Breast Examination Strategies: A Comparison with Current Guidelines. Cancer Epidemiol. Biomarkers Prev.
18: 718-725
[Abstract][Full Text]
Venkatesan, A., Chu, P., Kerlikowske, K., Sickles, E. A., Smith-Bindman, R.
(2009). Positive Predictive Value of Specific Mammographic Findings according to Reader and Patient Variables. Radiology
250: 648-657
[Abstract][Full Text]
Carlos, R. C.
(2009). Declining Screening Mammography Rates: A Multigenerational Loss of Opportunity?. Am. J. Roentgenol.
192: 388-389
[Full Text]
Wolf, A. B., Brem, R. F.
(2009). Decreased Mammography Utilization in the United States: Why and How Can We Reverse the Trend?. Am. J. Roentgenol.
192: 400-402
[Abstract][Full Text]
Dawood, S., Broglio, K., Kau, S.-W., Green, M. C., Giordano, S. H., Meric-Bernstam, F., Buchholz, T. A., Albarracin, C., Yang, W. T., Hennessy, B. T.J., Hortobagyi, G. N., Gonzalez-Angulo, A. M.
(2009). Triple Receptor-Negative Breast Cancer: The Effect of Race on Response to Primary Systemic Treatment and Survival Outcomes. JCO
27: 220-226
[Abstract][Full Text]
Harper, S., Lynch, J., Meersman, S. C., Breen, N., Davis, W. W., Reichman, M. C.
(2009). Trends in Area-Socioeconomic and Race-Ethnic Disparities in Breast Cancer Incidence, Stage at Diagnosis, Screening, Mortality, and Survival among Women Ages 50 Years and Over (1987-2005). Cancer Epidemiol. Biomarkers Prev.
18: 121-131
[Abstract][Full Text]
Coldman, A. J, Phillips, N., Olivotto, I. A, Gordon, P., Warren, L., Kan, L.
(2008). Impact of changing from annual to biennial mammographic screening on breast cancer outcomes in women aged 50-79 in British Columbia. J Med Screen
15: 182-187
[Abstract][Full Text]
DeLancey, J. O. L., Thun, M. J., Jemal, A., Ward, E. M.
(2008). Recent Trends in Black-White Disparities in Cancer Mortality. Cancer Epidemiol. Biomarkers Prev.
17: 2908-2912
[Abstract][Full Text]
Maillart, L. M., Ivy, J. S., Ransom, S., Diehl, K.
(2008). Assessing Dynamic Breast Cancer Screening Policies. Operations Research
56: 1411-1427
[Abstract]
Somlo, G., Chu, P., Frankel, P., Ye, W., Groshen, S., Doroshow, J. H., Danenberg, K., Danenberg, P.
(2008). Molecular profiling including epidermal growth factor receptor and p21 expression in high-risk breast cancer patients as indicators of outcome. Ann Oncol
19: 1853-1859
[Abstract][Full Text]
Berg, W. A., Mendelson, E. B.
(2008). Ultrasound and Mammography for Breast Cancer Screening--Reply. JAMA
300: 1515-1515
[Full Text]
Kuhl, C. K.
(2008). Nonmammographic Screening for Breast Cancer--Reply. JAMA
300: 1516-1517
[Full Text]
Goldstein, L. J., Gray, R., Badve, S., Childs, B. H., Yoshizawa, C., Rowley, S., Shak, S., Baehner, F. L., Ravdin, P. M., Davidson, N. E., Sledge, G. W. Jr, Perez, E. A., Shulman, L. N., Martino, S., Sparano, J. A.
(2008). Prognostic Utility of the 21-Gene Assay in Hormone Receptor-Positive Operable Breast Cancer Compared With Classical Clinicopathologic Features. JCO
26: 4063-4071
[Abstract][Full Text]
Lambertz, C. K., Johnson, C. J., Montgomery, P. G., Maxwell, J. R.
(2008). Premedication to Reduce Discomfort during Screening Mammography. Radiology
248: 765-772
[Abstract][Full Text]
Kinsey, T., Jemal, A., Liff, J., Ward, E., Thun, M.
(2008). Secular Trends in Mortality From Common Cancers in the United States by Educational Attainment, 1993-2001. JNCI J Natl Cancer Inst
100: 1003-1012
[Abstract][Full Text]
Aspy, C. B., Enright, M., Halstead, L., Mold, J. W.
(2008). Improving Mammography Screening Using Best Practices and Practice Enhancement Assistants: An Oklahoma Physicians Resource/Research Network (OKPRN) Study. J Am Board Fam Med
21: 326-333
[Abstract][Full Text]
Dhalla, I. A., Kiran, T., Golden, H. E., Trivedi, A. N., Rakowski, W., Ayanian, J. Z.
(2008). Effect of cost sharing on screening mammography.. NEJM
358: 2411-2411
[Full Text]
Mandelblatt, J. S., Cullen, J., Lawrence, W. F., Stanton, A. L., Yi, B., Kwan, L., Ganz, P. A.
(2008). Economic Evaluation Alongside a Clinical Trial of Psycho-Educational Interventions to Improve Adjustment to Survivorship Among Patients With Breast Cancer. JCO
26: 1684-1690
[Abstract][Full Text]
Mulshine, J. L.
(2008). Commentary: Lung Cancer Screening--Progress or Peril. The Oncologist
13: 435-438
[Full Text]
Ganz, P. A., Hussey, M. A., Moinpour, C. M., Unger, J. M., Hutchins, L. F., Dakhil, S. R., Giguere, J. K., Goodwin, J. W., Martino, S., Albain, K. S.
(2008). Late Cardiac Effects of Adjuvant Chemotherapy in Breast Cancer Survivors Treated on Southwest Oncology Group Protocol S8897. JCO
26: 1223-1230
[Abstract][Full Text]
Giordano, S. H., Hortobagyi, G. N.
(2008). Time to Remove the Subspecialty Blinders: Breast Cancer Does Not Exist in Isolation. JNCI J Natl Cancer Inst
100: 230-231
[Full Text]
Wolff, A. C., Berry, D., Carey, L. A., Colleoni, M., Dowsett, M., Ellis, M., Garber, J. E., Mankoff, D., Paik, S., Pusztai, L., Lou Smith, M., Zujewski, J.
(2008). Research Issues Affecting Preoperative Systemic Therapy for Operable Breast Cancer. JCO
26: 806-813
[Abstract][Full Text]
Kahn, K. L.
(2008). Moving Research From Bench to Bedside to Community: There Is Still More to Do. JCO
26: 523-526
[Full Text]
Tosteson, A. N.A., Stout, N. K., Fryback, D. G., Acharyya, S., Herman, B. A., Hannah, L. G., Pisano, E. D., for the DMIST Investigators,
(2008). Cost-Effectiveness of Digital Mammography Breast Cancer Screening. ANN INTERN MED
148: 1-10
[Abstract][Full Text]
Casey, P. M., Cerhan, J. R., Pruthi, S.
(2008). Oral Contraceptive Use and the Risk of Breast Cancer. Mayo Clin Proc.
83: 86-91
[Abstract][Full Text]
Brenner, H., Gondos, A., Arndt, V.
(2007). Recent Major Progress in Long-Term Cancer Patient Survival Disclosed by Modeled Period Analysis. JCO
25: 3274-3280
[Abstract][Full Text]
Glass, A. G., Lacey, J. V. Jr, Carreon, J. D., Hoover, R. N.
(2007). Breast Cancer Incidence, 1980 2006: Combined Roles of Menopausal Hormone Therapy, Screening Mammography, and Estrogen Receptor Status. JNCI J Natl Cancer Inst
99: 1152-1161
[Abstract][Full Text]
Pruthi, S., Brandt, K. R., Degnim, A. C., Goetz, M. P., Perez, E. A., Reynolds, C. A., Schomberg, P. J., Dy, G. K., Ingle, J. N.
(2007). A Multidisciplinary Approach to the Management of Breast Cancer, Part 1: Prevention and Diagnosis. Mayo Clin Proc.
82: 999-1012
[Abstract][Full Text]
Henry, N. L., Hayes, D. F.
(2007). Can Biology Trump Anatomy? Do All Node-Positive Patients With Breast Cancer Need Chemotherapy?. JCO
25: 2501-2503
[Full Text]
Punglia, R. S., Morrow, M., Winer, E. P., Harris, J. R.
(2007). Local Therapy and Survival in Breast Cancer. NEJM
356: 2399-2405
[Full Text]
The Mount Hood 4 Modeling Group,
(2007). Computer Modeling of Diabetes and Its Complications: A report on the Fourth Mount Hood Challenge Meeting. Diabetes Care
30: 1638-1646
[Abstract][Full Text]
Jatoi, I., Chen, B. E., Anderson, W. F., Rosenberg, P. S.
(2007). Breast Cancer Mortality Trends in the United States According to Estrogen Receptor Status and Age at Diagnosis. JCO
25: 1683-1690
[Abstract][Full Text]
Ravdin, P. M., Cronin, K. A., Howlader, N., Berg, C. D., Chlebowski, R. T., Feuer, E. J., Edwards, B. K., Berry, D. A.
(2007). The Decrease in Breast-Cancer Incidence in 2003 in the United States. NEJM
356: 1670-1674
[Abstract][Full Text]
Brewer, N. T., Salz, T., Lillie, S. E.
(2007). Systematic Review: The Long-Term Effects of False-Positive Mammograms. ANN INTERN MED
146: 502-510
[Abstract][Full Text]
Qaseem, A., Snow, V., Sherif, K., Aronson, M., Weiss, K. B., Owens, D. K., for the Clinical Efficacy Assessment Subcommittee,
(2007). Screening Mammography for Women 40 to 49 Years of Age: A Clinical Practice Guideline from the American College of Physicians. ANN INTERN MED
146: 511-515
[Abstract][Full Text]
Smith, R. A.
(2007). The Evolving Role of MRI in the Detection and Evaluation of Breast Cancer. NEJM
356: 1362-1364
[Full Text]
(2007). The Utility of Screening Mammography. JWatch Women's Health
2007: 1-1
[Full Text]
Woo, P. P.S., Kim, J. J., Leung, G. M.
(2007). What Is the Most Cost-Effective Population-Based Cancer Screening Program for Chinese Women?. JCO
25: 617-624
[Abstract][Full Text]
Lillie, S. E., Brewer, N. T., O'Neill, S. C., Morrill, E. F., Dees, E. C., Carey, L. A., Rimer, B. K.
(2007). Retention and Use of Breast Cancer Recurrence Risk Information from Genomic Tests: The Role of Health Literacy. Cancer Epidemiol. Biomarkers Prev.
16: 249-255
[Abstract][Full Text]
Antoine, C., Liebens, F., Carly, B., Pastijn, A., Neusy, S., Rozenberg, S.
(2007). Safety of hormone therapy after breast cancer: a qualitative systematic review. Hum Reprod
22: 616-622
[Abstract][Full Text]
Knudsen, A. B., McMahon, P. M., Gazelle, G. S.
(2007). Use of Modeling to Evaluate the Cost-Effectiveness of Cancer Screening Programs. JCO
25: 203-208
[Abstract][Full Text]
Gramling, R. E., Vidrine, J. I.
(2007). Risk Communication During Screening for Genomic Breast Cancer Susceptibility. AMERICAN JOURNAL OF LIFESTYLE MEDICINE
1: 54-58
[Abstract]
Schoder, H., Gonen, M.
(2007). Screening for Cancer with PET and PET/CT: Potential and Limitations. JNM
48: 4S-18S
[Abstract][Full Text]
Hayat, M. J., Howlader, N., Reichman, M. E., Edwards, B. K.
(2007). Cancer Statistics, Trends, and Multiple Primary Cancer Analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. The Oncologist
12: 20-37
[Abstract][Full Text]
Cancer Intervention and Surveillance Modeling Netw,
(2006). Executive Summary. J Natl Cancer Inst Monogr
2006: 1-2
[Full Text]
Habbema, J. D. F., Tan, S. Y. G. L., Cronin, K. A.
(2006). Chapter 14: Impact of Mammography on U.S. Breast Cancer Mortality, 1975-2000: Are Intermediate Outcome Measures Informative?. J Natl Cancer Inst Monogr
2006: 105-111
[Abstract][Full Text]
Cronin, K. A., Feuer, E. J., Clarke, L. D., Plevritis, S. K.
(2006). Chapter 15: Impact of Adjuvant Therapy and Mammography on U.S. Mortality From 1975 to 2000: Comparison of Mortality Results From the CISNET Breast Cancer Base Case Analysis. J Natl Cancer Inst Monogr
2006: 112-121
[Abstract][Full Text]
Habbema, J. D. F., Schechter, C. B., Cronin, K. A., Clarke, L. D., Feuer, E. J.
(2006). Chapter 16: Modeling Cancer Natural History, Epidemiology, and Control: Reflections on the CISNET Breast Group Experience. J Natl Cancer Inst Monogr
2006: 122-126
[Full Text]
Smith, B. D., Haffty, B. G., Buchholz, T. A., Smith, G. L., Galusha, D. H., Bekelman, J. E., Gross, C. P.
(2006). Effectiveness of radiation therapy in older women with ductal carcinoma in situ.. JNCI J Natl Cancer Inst
98: 1302-1310
[Abstract][Full Text]
Swain, S. M.
(2006). A Step in the Right Direction. JCO
24: 3717-3718
[Full Text]
Krag, D. N., Shukla, G. S., Shen, G.-P., Pero, S., Ashikaga, T., Fuller, S., Weaver, D. L., Burdette-Radoux, S., Thomas, C.
(2006). Selection of Tumor-binding Ligands in Cancer Patients with Phage Display Libraries.. Cancer Res.
66: 7724-7733
[Abstract][Full Text]
Stout, N. K., Rosenberg, M. A., Trentham-Dietz, A., Smith, M. A., Robinson, S. M., Fryback, D. G.
(2006). Retrospective cost-effectiveness analysis of screening mammography.. JNCI J Natl Cancer Inst
98: 774-782
[Abstract][Full Text]
Henry, N. L., Hayes, D. F.
(2006). Uses and abuses of tumor markers in the diagnosis, monitoring, and treatment of primary and metastatic breast cancer.. The Oncologist
11: 541-552
[Abstract][Full Text]
Plevritis, S. K., Kurian, A. W., Sigal, B. M., Daniel, B. L., Ikeda, D. M., Stockdale, F. E., Garber, A. M.
(2006). Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging.. JAMA
295: 2374-2384
[Abstract][Full Text]
Grann, V. R., Muggia, F. M.
(2006). Completion rates of adjuvant chemotherapy for colon cancer: a historical perspective.. JNCI J Natl Cancer Inst
98: 570-571
[Full Text]
Smigal, C., Jemal, A., Ward, E., Cokkinides, V., Smith, R., Howe, H. L., Thun, M.
(2006). Trends in breast cancer by race and ethnicity: update 2006.. CA Cancer J Clin
56: 168-183
[Abstract][Full Text]
Smith-Bindman, R., Miglioretti, D. L., Lurie, N., Abraham, L., Barbash, R. B., Strzelczyk, J., Dignan, M., Barlow, W. E., Beasley, C. M., Kerlikowske, K.
(2006). Does utilization of screening mammography explain racial and ethnic differences in breast cancer?. ANN INTERN MED
144: 541-553
[Abstract][Full Text]
Berry, D. A., Cirrincione, C., Henderson, I. C., Citron, M. L., Budman, D. R., Goldstein, L. J., Martino, S., Perez, E. A., Muss, H. B., Norton, L., Hudis, C., Winer, E. P.
(2006). Estrogen-Receptor Status and Outcomes of Modern Chemotherapy for Patients With Node-Positive Breast Cancer. JAMA
295: 1658-1667
[Abstract][Full Text]
Zackrisson, S., Andersson, I., Janzon, L., Manjer, J., Garne, J. P.
(2006). Rate of over-diagnosis of breast cancer 15 years after end of Malmo mammographic screening trial: follow-up study. BMJ
332: 689-692
[Abstract][Full Text]
Dixon, J M.
(2006). Screening for breast cancer.. BMJ
332: 499-500
[Full Text]
Baker, S. G., Gotzsche, P. C., Baglioni, P., Smith, D. W., Retsky, M. W., Demicheli, R., Hrushesky, W. J.M., Berry, D. A., Plevritis, S. K., Fryback, D. G.
(2006). Screening and breast cancer.. NEJM
354: 767-769
[Full Text]
Buzdar, A. U.
(2006). Dietary Modification and Risk of Breast Cancer. JAMA
295: 691-692
[Full Text]
Baker, S. G, Kramer, B. S, McIntosh, M., Patterson, B. H, Shyr, Y., Skates, S.
(2006). Evaluating markers for the early detection of cancer: overview of study designs and methods. Clin Trials
3: 43-56
[Abstract]
Murata, S., Kominsky, S. L., Vali, M., Zhang, Z., Garrett-Mayer, E., Korz, D., Huso, D., Baker, S. D., Barber, J., Jaffee, E., Reilly, R. T., Sukumar, S.
(2006). Ductal Access for Prevention and Therapy of Mammary Tumors. Cancer Res.
66: 638-645
[Abstract][Full Text]
Swain, S. M.
(2005). Aromatase Inhibitors -- A Triumph of Translational Oncology. NEJM
353: 2807-2809
[Full Text]
Previous
